Advances in the role of SIRT3-mediated mitochondrial function and metabolic regulation in diabetes mellitus type 2

Abstract

Abstract: Diabetes mellitus type 2(T2DM) has a high morbidity because there is no specific treatment. Mitochondrial injury and metabolic disorder are the most important pathophysiological manifestations of T2DM. So it is essential to maintain mitochondrial function and cell metabolic homeostasis. Mitochondrial deacetylase silence information regulator 3 (SIRT3) is crucial for the regulation of respiratory enzymes, for antagonizing oxidative stress and promoting mitochondrial autophagy as well as glucose uptake.

Key words: SIRT3, mitochondria, metabolism, diabetes mellitus type 2

CLC Number:

R363

YANG Jing, LI Min. Advances in the role of SIRT3-mediated mitochondrial function and metabolic regulation in diabetes mellitus type 2[J]. Basic & Clinical Medicine, 2021, 41(12): 1828-1832.

References

[1]杨丹, 崔雅忠, 张倩, 等. 1型与2型糖尿病大鼠周围神经病变的比较[J]. 基础医学与临床, 2019, 39:27-31.
[2]骆时木, 欧阳航, 蒋燕成, 等. TCF7L2 rs290481基因多态性与2型糖尿病合并冠心病相关[J]. 基础医学与临床, 2020, 40:1484-1488.
[3]Maghbooli Z, Emamgholipour S, Aliakbar S, et al. Differential expressions of Sirt1, Sirt3, and Sirt4 in peripheral blood mononuclear cells from patients with type 2 diabetic retinopathy[J]. Arch Physiol Biochem, 2020, 126: 363-368.
[4]Ogura Y, Kitada M, Xu J, et al. Cd38 inhibition by apigenin ameliorates mitochondrial oxidative stress through restoration of the intracellular nad(+)/nadh ratio and sirt3 activity in renal tubular cells in diabetic rats[J]. Aging (Albany NY), 2020, 12: 11325-11336.
[5]Carrico C, Meyer JG, He W, et al. The mitochondrial acylome emerges: proteomics, regulation by sirtuins, and metabolic and disease implications[J]. Cell Metab, 2018, 27: 497-512.
[6]Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents[J]. Curr Diabetes Rev, 2020, 16: 220-229.
[7]Yuxin H, Cuiping J, Wen T, et al. Comparison of gastrointestinal adverse events with different doses of metformin in the treatment of elderly people with type 2 diabetes[J]. J Clin Pharm Ther, 2020, 45: 470-476. doi: 10.1111/jcpt.13087.
[8]Zhang J, Xiang H, Liu J, et al. Mitochondrial sirtuin 3: new emerging biological function and therapeutic target[J]. Theranostics, 2020, 10: 8315-8342.
[9]Cortes-Rojo C, Vargas-Vargas MA, Olmos-Orizaba BE, et al. Interplay between nadh oxidation by complex i, glutathione redox state and sirtuin-3, and its role in the development of insulin resistance[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866: 165801. doi: 10.1016/j.bbadis.2020.165801.
[10]Dai SH, Chen T, Wang YH, et al. Sirt3 protects cortical neurons against oxidative stress via regulating mitochon-drial Ca²⁺ and mitochondrial biogenesis[J]. Int J Mol Sci, 2014, 15: 14591-14609. doi: 10.3390/ijms150814591.
[11]Gao P, Jiang Y, Wu H, et al. Inhibition of mitochondrial calcium overload by sirt3 prevents obesity- or age-related whitening of brown adipose tissue[J]. Diabetes, 2020, 69: 165-180.
[12]Gao Z, Wang Z, Zhu H, et al. Hyperinsulinemia contributes to impaired-glucose-tolerance-induced renal injury via mir-7977/sirt3 signaling[J]. Ther Adv Chronic Dis, 2020, 11: 2040622320916008. doi: 10.1177/2040622320916008.
[13]He F, Huang Y, Song Z, et al. Mitophagy-mediated adipose inflammation contributes to type 2 diabetes with hepatic insulin resistance[J]. J Exp Med, 2021, 218.doi: 10.1084/jem.20201416.
[14]Lantier L, Williams AS, Williams IM, et al. Sirt3 is crucial for maintaining skeletal muscle insulin action and protects against severe insulin resistance in high-fat-fed mice[J]. Diabetes, 2015, 64: 3081-3092. doi: 10.2337/db14-1810.
[15]Ogura Y, Kitada M, Monno I, et al. Renal mitochondrial oxidative stress is enhanced by the reduction of sirt3 activity, in zucker diabetic fatty rats[J]. Redox Rep, 2018, 23: 153-159.
[16]Rovira-Llopis S, Banuls C, Diaz-Morales N, et al. Mitochondrial dynamics in type 2 diabetes: pathophysiological implications[J]. Redox Biol, 2017, 11: 637-645.
[17]Vassilopoulos A, Pennington JD, Andresson T, et al. Sirt3 deacetylates atp synthase f1 complex proteins in response to nutrient- and exercise-induced stress[J]. Antioxid Redox Signal, 2014, 21: 551-564. doi: 10.1089/ars.2013.5420.
[18]Wanner C, Lachin JM, Inzucchi SE, et al. Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease[J]. Circulation, 2018, 137: 119-129.
[19]Yang S, Xu M, Meng G, et al. Sirt3 deficiency delays diabetic skin wound healing via oxidative stress and necroptosis enhancement[J]. J Cell Mol Med, 2020, 24: 4415-4427.
[20]Yerra VG, Areti A, Kumar A. Adenosine monophosphate-activated protein kinase abates hyperglycaemia-induced neuronal injury in experimental models of diabetic neuropathy: effects on mitochondrial biogenesis, autophagy and neuroinflammation[J]. Mol Neurobiol, 2017, 54: 2301-2312.
[21]Yu W, Gao B, Li N, et al. Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of foxo3a-parkin-mediated mitophagy[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863: 1973-1983.
[22]Zeng H, He X, Chen JX. Endothelial sirtuin 3 dictates glucose transport to cardiomyocyte and sensitizes pressure overload-induced heart failure[J]. J Am Heart Assoc, 2020, 9: e015895. doi: 10.1161/JAHA.120.015895.
[23]Zhang Y, Bharathi SS, Rardin MJ, et al. Sirt3 and sirt5 regulate the enzyme activity and cardiolipin binding of very long-chain acyl-coa dehydrogenase[J]. PLoS One, 2015, 10: e0122297. doi: 10.1371/journal.pone.0122297.
[24]Zhao H, Matsuzaka T, Nakano Y, et al. Elovl6 defici-ency improves glycemic control in diabetic db/db mice by expanding beta-cell mass and increasing insulin secretory capacity[J]. Diabetes, 2017, 66: 1833-1846.
[25]Zhou Y, Chung ACK, Fan R, et al. Sirt3 deficiency increased the vulnerability of pancreatic beta cells to oxidative stress-induced dysfunction[J]. Antioxid Redox Signal, 2017, 27: 962-976.